Celyad Oncology (NASDAQ: CYAD)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 0.09 expecting CYAD to fall to within 12 months (a possible -95.63% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Celyad Oncology (NASDAQ: CYAD) is $2.06 last updated August 11, 2022, 5:48 PM UTC.
The next Celyad Oncology (CYAD) dividend date is projected to be Monday, August 22, 2022.
Celyad Oncology’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Celyad Oncology.
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.